A Study of Mirdametinib in Combination With Palbociclib in People With Liposarcoma
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Milton S. Hershey Medical Center
Royal Marsden NHS Foundation Trust
Mario Negri Institute for Pharmacological Research
Seattle Children's Hospital
Australia and New Zealand Sarcoma Association
Oslo University Hospital
Oslo University Hospital
St. Jude Children's Research Hospital
Baylor College of Medicine
Rezolute